Literature DB >> 872453

Increased serum IgD concentrations in patients with Hodgkin's disease.

G Corte, M Ferrarini, P Tonda, A Bargellesi.   

Abstract

Serum IgD concentrations have been determined in twenty-one patients with Hodgkin's disease, in eight patients with non-Hodgkin's lymphomas and in twenty-eight normal (control) individuals by both a solidphase radio-immuno-assay and radial-immunodiffusion. Fourteen of the Hodgkin's patients displayed three to forty-five-fold increased serum IgD levels as compared to control individuals, while in the remaining seven patients IgD concentrations were practically normal. Patients with non-Hodgkin's lymphomas had decreased IgD concentrations.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 872453      PMCID： PMC1540758     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  13 in total

1.  The correlation of serum IgD concentration with Gm allotype.

Authors:  P D Walzer; H G Kunkel
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

2.  The nature of Reed-Sternberg cells and other malignant "reticulum" cells.

Authors:  C R Taylor
Journal:  Lancet       Date:  1974-10-05       Impact factor: 79.321

3.  Immunoglobulin D in serum, body fluids and lymphoid tissues.

Authors:  D S Rowe; P A Crabbé; M W Turner
Journal:  Clin Exp Immunol       Date:  1968-07       Impact factor: 4.330

4.  Serum levels of immune globulins in health and disease: a survey.

Authors:  E R Stiehm; H H Fudenberg
Journal:  Pediatrics       Date:  1966-05       Impact factor: 7.124

5.  Serum IgD concentrations in sarcoidosis and tuberculosis.

Authors:  C E Buckley; H R Trayer
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

6.  An enzymic method for the trace iodination of immunoglobulins and other proteins.

Authors:  J J Marchalonis
Journal:  Biochem J       Date:  1969-06       Impact factor: 3.857

7.  Serum IgD and IgE concentrations in immunodeficiency diseases.

Authors:  R H Buckley; S A Fiscus
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

8.  Purification of Hodgkin's disease tumor-associated antigens.

Authors:  D H Katz; S E Order; M Graves; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

9.  Immunohistochemical demonstration of IgG in Reed-Sternberg and other cells in Hodgkin's disease.

Authors:  A J Garvin; S S Spicer; R T Parmley; A M Munster
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

10.  A NEW CLASS OF HUMAN IMMUNOGLOBULINS. II. NORMAL SERUM IGD.

Authors:  D S ROWE; J L FAHEY
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307
View more
  5 in total

Review 1.  Immunoglobulin D: properties, measurement, and clinical relevance.

Authors:  A O Vladutiu
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Hyperimmunoglobulinaemia D and periodic fever mimicking familial Mediterranean fever in the Mediterranean.

Authors:  R Topaloğlu; U Saatçi
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

3.  Biosynthesis and characterization of intracellular IgDkappa in a case of CLL.

Authors:  J Gordon; J L Smith; D Newell; M Chisholm; G Corte; A Warley; N Richardson
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

4.  Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.

Authors:  S Romagnani; G F Del Prete; E Maggi; G Bellesi; G Biti; P L Rossi Ferrini; M Ricci
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

5.  Serum IgD elevation is an early marker of B cell activation during infection with the human immunodeficiency viruses.

Authors:  H Mizuma; S Zolla-Pazner; S Litwin; W el-Sadr; S Sharpe; B Zehr; S Weiss; W C Saxinger; M Marmor
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.